Armaceutica, Inc.: Clinical Trials

1 trial sponsored by Armaceutica, Inc., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 suspended. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Suspended 1

Follow Armaceutica, Inc.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pyronaridine in Acute Myeloid Leukemia (AML)
Pyronaridine Tetraphosphate - Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL)
Phase 2SuspendedArmaceutica, Inc.2002028-02-212026-10-19

Conditions studied

Leukemia (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Neoplasms (1)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)

Interventions

pyronaridine (1)

Countries

Senegal (1)

Top investigators

Renato J Aguilera, PhD (1)